Timepoint | Study periods | ||
---|---|---|---|
Enrollment | Initial assessment | Follow-up | |
- t1 | 0 | ti:delay to 6 months to 1 year | |
Enrolment: | |||
Eligibility screen | X | ||
Information to patients/careviger | X | ||
Collection of non-opposition to participate | X | ||
Date of the visit | X | X | X |
Assessments: | |||
Primary outcome: | |||
Functional autonomy level (IADL, DAD-6) | X | X | |
Secondary outcomes: | |||
Global cognitive performance (MMSE) | X | X | |
Behavioral disorders (NPI) | X | X | |
Characteristics: | |||
Sociodemographic data (age, gender, educational level, socio professional categories, marital status, geographical location) | X | ||
Relationship with the primary caregiver | X | ||
Current lifestyle | X | ||
Patient protection measure | X | ||
Neuropsychological evaluation | X | X | |
Diagnosis and stage | X | X | |
Comorbidities, lifestyle habits | X | ||
Pharmaceutical therapeutics | X | X | |
Non-pharmaceutical therapeutics | X | X | |
Caregiver burden (Mini-Zarit) | X | X |